Benzinga's Top #PreMarket Losers
September 15, 2014 at 08:15 AM EDT
NPS Pharmaceuticals (NASDAQ: NPSP) fell 10.70% to $29.20 in pre-market trading. The FDA has voted 8-5 in favor of NPS Pharmaceuticals' ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.